Montomoli E - Search Results

1

Egg-Independent Influenza Vaccines and Vaccine Candidates.

Manini I, Trombetta CM, Lazzeri G, Pozzi T, Rossi S, Montomoli E. Manini I, et al. Among authors: montomoli e. Vaccines (Basel). 2017 Jul 18;5(3):18. doi: 10.3390/vaccines5030018. Vaccines (Basel). 2017. PMID: 28718786 Free PMC article. Review.

2

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects.

Gasparini R, Pozzi T, Montomoli E, Fragapane E, Senatore F, Minutello M, Podda A. Gasparini R, et al. Among authors: montomoli e. Eur J Epidemiol. 2001;17(2):135-40. doi: 10.1023/a:1017919305501. Eur J Epidemiol. 2001. PMID: 11599686 Clinical Trial.

3

Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy.

Pütz MM, Alberini I, Midgley CM, Manini I, Montomoli E, Smith GL. Pütz MM, et al. Among authors: montomoli e. J Gen Virol. 2005 Nov;86(Pt 11):2955-2960. doi: 10.1099/vir.0.81265-0. J Gen Virol. 2005. PMID: 16227216

4

Pre-emptive vaccination against pandemic influenza virus.

Montomoli E, Manini I. Montomoli E, et al. Vaccine. 2007 Mar 1;25(11):1921-2. doi: 10.1016/j.vaccine.2006.11.026. Epub 2006 Nov 28. Vaccine. 2007. PMID: 17241706 No abstract available.

5

Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?

Alfonsi V, Montomoli E, Manini I, Alberini I, Gentile C, Rota MC, Ciofi degli Atti ML. Alfonsi V, et al. Among authors: montomoli e. Vaccine. 2007 Aug 10;25(32):6086-8. doi: 10.1016/j.vaccine.2007.05.019. Epub 2007 Jun 4. Vaccine. 2007. PMID: 17629374

6

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

Wack A, Baudner BC, Hilbert AK, Manini I, Nuti S, Tavarini S, Scheffczik H, Ugozzoli M, Singh M, Kazzaz J, Montomoli E, Del Giudice G, Rappuoli R, O'Hagan DT. Wack A, et al. Among authors: montomoli e. Vaccine. 2008 Jan 24;26(4):552-61. doi: 10.1016/j.vaccine.2007.11.054. Epub 2007 Dec 7. Vaccine. 2008. PMID: 18162266

7

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial.

Groth N, Montomoli E, Gentile C, Manini I, Bugarini R, Podda A. Groth N, et al. Among authors: montomoli e. Vaccine. 2009 Jan 29;27(5):786-91. doi: 10.1016/j.vaccine.2008.11.003. Epub 2008 Nov 21. Vaccine. 2009. PMID: 19027046 Clinical Trial.

8

Hepatitis A seroprevalence in Tuscany, Italy.

Gentile C, Alberini I, Manini I, Rossi S, Montomoli E, Pozzi T, Rizzo C, Alfonsi V. Gentile C, et al. Among authors: montomoli e. Euro Surveill. 2009 Mar 12;14(10):19146. Euro Surveill. 2009. PMID: 19317984 Free article.

9

Current adjuvants and new perspectives in vaccine formulation.

Montomoli E, Piccirella S, Khadang B, Mennitto E, Camerini R, De Rosa A. Montomoli E, et al. Expert Rev Vaccines. 2011 Jul;10(7):1053-61. doi: 10.1586/erv.11.48. Expert Rev Vaccines. 2011. PMID: 21806399 Review.

10

Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.

Montomoli E, Khadang B, Piccirella S, Trombetta C, Mennitto E, Manini I, Stanzani V, Lapini G. Montomoli E, et al. Expert Rev Vaccines. 2012 May;11(5):587-94. doi: 10.1586/erv.12.24. Expert Rev Vaccines. 2012. PMID: 22827244 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page